Nowadays, treatment decisions, as well as detection of recurrent disease and monitoring therapy, are mostly performed by predictive and diagnostic biomarkers (
23).
Appropriate biomarkers should be stable and non-invasive, and ought to be disease-specific for reliable and accurate measurement across a diseased population (
24). It is recommended that due to the prevalence of miRNA regulation, it should participate in a wide range of human-specific diseases. It is proposed that such regulators have critical functions, such as oncogenes or tumor suppressor genes in various types of cancers (
25). For instance, miR-16, as well as miR-15, frequently undergo deletion in different types of leukemia (
26) and miR-182, miR-96, and miR-183 expressions correlate with the progression of non-small cell lung cancer (
27). Also, miR-423-5P (
28), miR-16 (
29), miR-139-5P (
30), miR-182, and miR-187 (
31) are among the detected miRNAs used as biomarkers in cancer diagnosis. They are also involved in some other diseases, such as immunological, psychiatric, and neurodegenerative ones (
32). Down-regulation of the biogenesis factors (
33), a mutation in the miRNA locus (
34), or epigenetic changes-e g, hypermethylation (
35), can perturb the miRNA function. Prior to investigating the role of miRNA in a disease, it should be predicted and annotated, according to its specific expression pattern. Then, by artificially altering the expression level of miRNAs, the initiation and progression of the diseases could be controlled. This issue is used to treat cardiovascular diseases-eg, cardiopulmonary resuscitation (
36), cardiac calcium signaling (
37), and cardiac repair after myocardial infarction (
38). Thus, predicting miRNA is a substantial step of primary analysis in the clinical context.
The discovery of novel miRNAs eventually results in an alteration in treatment attitudes, enhanced clinical results, higher allocation of health care resources, and increased utilization of miRNA-based therapy (
39). More miRNAs are detected by extensive cloning and sequencing. The major limitation of miRNA detection by cloning is that it is troublesome to find miRNAs with low expression levels, expressed per cell at different stages of development, or exhibit tissue-restricted expression. Nevertheless, the process of miRNA cloning, according to their physical characteristics, such as post-translational modifications or nucleotide sequences, is not easily achieved. Additionally, expensive and time-consuming cloning techniques added more limitations as well (
40). Computational algorithms can be used to provide quick, efficient, and inexpensive methods to detect and predict miRNA coding sequences in the genome. It should be confirmed in-vitro by examining the expression of the endogenous miRNA mature form (
41).
Lai et al., according to the expression profiling and bioinformatics analyses, suggested about 24 new target genes for human miRNAs (
42); furthermore, Hoballa et al., consistent to the bioinformatics prediction, introduced two novel miRZa-3p and miRZa-5p, which target SMAD3 and IGF1R genes (
43).
Bentwich et al., also introduced a total of 89 novel human miRNAs in a broad study, combining bioinformatics predictions with microarray analysis and sequence-directed cloning (
44). Dokanehiifard et al., using the SSCprofiler, UCSC genome browser, and several other databases, predicted and validated two novel miRNAs in the TrkC gene, as well as hsa-miR-6165 in the NGFR gene, and also investigated their possible association with colorectal cancer (
45). Additionally, in a similar fashion, they predicted and confirmed a new miRNA in the PIK3KCA gene with a possible role in colorectal cancer (
46).
Lim et al., using RNAfold web server to analyze folding and minimum free energy, predicted structures such as miRNA precursors and identified 38 novel human miRNAs (
47); Wu et al., completely validated the novel hsa-miR-3675b that inhibited proliferation of human breast carcinoma cells (
48).
5.1. Conclusion
The current study aimed at scanning the F8 gene in the contemplation of predicting and identifying potential sequences for the expression of mature miRNAs. Hemophilia A is a monogenic disorder; hence, a vast majority of the known and recorded human miRNAs affect the expression levels of their coding genes.
The present study used a highly accurate and reliable database. Hopefully, the proposed candidate sequences are experimentally approved in future studies and, subsequently, have a high impact upon initiation, advancement, and improvement of miRNA-based medicines aimed at treating and healing the long-suffering patients with hemophilia A.